The Hormonal and Reproductive Epidemiology Branch (HREB) conducts research to identify groups at high risk of cancer, clarify the natural history of various cancers, understand the interactive effects of genetic and environmental factors on cancer risk, and elucidate biologic mechanisms of carcinogenesis.
HREB's research mission is to focus on hormonal and reproductive cancers, and other malignancies with possible hormonal etiologies (e.g., liver, esophageal). Learn about specific HREB research areas.
HREB fellows enjoy unique opportunities to collaborate and learn from investigators in a world-renowned research program. Fellows have access to large population-based studies with biological specimens and are encouraged to initiate new investigations and to compete for funding. Meet the current HREB fellows and learn about research training opportunities in HREB.
HREB launched the Distinguished Lecture Series in 2004. Each year, a prominent scientist is invited to visit for two days to give a lecture and meet with DCEG staff to discuss issues relevant to research on causes of hormonal and reproductive cancers. The objectives of this series are to expand and intensify contacts between intramural and extramural investigators, provide an opportunity for junior staff to meet with distinguished scientists, and stimulate new opportunities for research in the area of hormonal and reproductive cancers. Read more about the HREB Distinguished Lecture Series.
HREB is pleased to announce the appointment of Michael B. Cook as a new tenure-track investigator. Read more on Dr. Michael Cook.
HREB is pleased to announce that Katherine McGlynn has been appointed as Deputy Chief of HREB. Read more on Dr. Katherine McGlynn.
HREB would like to congratulate Dr. Vikrant Sahasrabuddhe for winning the IAS/ANRS Young Investigator Award for his abstract “HPV genotype attribution of anal neoplasia in HIV-positive MSM: Estimating the preventable fraction and disease misclassification.”
Wentzensen N, Black A, et al. Genetic variation on 9p22 is associated with abnormal ovarian ultrasound results in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. PLoS One 2011;6:e21731
Figueroa JD, Garcia-Closas M, et al. Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: Findings from the Breast Cancer Association Consortium. Hum Mol Genet. 2011; Aug 18 (E-pub)
McGlynn KA, London WT. The global epidemiology of hepatocellular carcinoma: Present and future. Clin Liver Dis. 2011;15:223-43